March 16, 2022 -- Thermo Fisher Scientific will invest $97 million to expand its clinical research operations in Richmond, VA. The facilities will support increasing demand across biopharma for consistent, high quality laboratory services to accelerate drug development, the company said.
The company expects to add nearly 150,000 sq ft and more than 500 new employees in Richmond over the next three years. The existing laboratory services operation in Richmond comprises more than 300,000 sq ft, with more than 1,200 employees.
The bulk of the expansion will occur in immunochemistry and chromatography functions, as well as subsequent enhancements in biomarker and vaccine sciences, the company noted.